Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Registered Investment Advisors See Wire Fraud, AI Errors as Emerging Threats to their Business, According to Golsan Scruggs 2025 Risk Survey
-
AlphaTON (Nasdaq:ATON) and Cyncado Therapeutics: Preclinical Mesothelioma Data Show Direct A2B Tumor Activity; TT-4 Achieved >90% Tumor Growth Inhibition; First-Patient Dosing on Track for Q1 2026
-
WEBs Investments Announces Name Changes for Defined Volatility℠ ETFs
-
Verizon Expanding Broadband with New Strategic Fiber Agreement
-
Harvard-Stanford Study Features Byrna as the Exclusive Product Used to Measure Shift in Gun-Owner Attitudes Toward Non-Lethal Personal Defense
-
Aspida Life Insurance Company Launches RILA
-
Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program
-
Baylor University and Cordia Partner to Advance Sustainable Campus Energy Future
-
Bottomline Announces Embedded AI Agent to Transform Treasury and Cash Management
-
Access Softek Partners with Array to Deliver Embedded Credit, Identity, Privacy Tools and More in Digital Banking
-
Medera Announces First Patient Dosed in Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial Evaluating SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
-
Synergy CHC Corp. (NASDAQ: SNYR) Announces FOCUSfactor® Named #1 Pharmacist Recommended OTC Memory Supplement for 2025-2026
-
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
-
TeleSpecialists Expands TeleEEG Service Line with Comprehensive Coverage Across All Study Types
-
Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference
-
Absci to Participate in Upcoming Investor Conferences
-
Greenridge Exploration Receives Airborne MobileMT Survey Results for the Sabre Uranium Project in Athabasca Basin, Saskatchewan
-
Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025
-
Pave Bank raises $39 million to scale world’s first programmable bank built for digital assets and AI era
-
Schouw & Co. share buy-back programme, week 43 2025
-
Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer
-
Signify share repurchase period update
-
OXB to participate in upcoming investor conferences and events
-
Rectitude Holdings Partners with Pansik Technology Pte Ltd. to Drive Expansion in Renewable Energy Solutions
-
Rectitude Holdings Partners with Pansik Technology Pte Ltd. to Drive Expansion in Renewable Energy Solutions
-
KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in Saudi Arabia
-
Abstract’s Founder to Discuss How Real-World Experience Is Shaping the Path to AGI at Future Lawyer USA 2025
-
Sydbank A/S share buyback programme: transactions in week 43
-
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
-
BexBack Launches Crypto Futures Trading with Up to 100x Leverage, No KYC Access and $100 Welcome Bonus
-
Form 8.3 - Avadel Pharmaceuticals plc
-
LIFE AI Joins First Ever FastTrack AI Accelerator Powered By GenAI Fund and NVIDIA Inception Program
-
Abaxx Exchange Integrates with TradingView, Extending LNG and Singapore Gold Futures Contract Liquidity to 100M+ Users
-
Blaqclouds Executes Blockchain Partnership with Super Studios USA, Led by Former Ridley Scott & Associates Executive Producer Developing a Billion-Dollar Entertainment Complex in Texas
-
Intellia Therapeutics Provides Update on MAGNITUDE Clinical Trials of Nexiguran Ziclumeran (nex-z)
-
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
-
BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market
-
MicrobiotiX Receives IND Approval for Novel Bacteriophage Drug MP101
-
Zevra Therapeutics Announces Details for Q3 2025 Financial Results Call
-
Telesat schedules third quarter 2025 earnings conference call for November 4, 2025
-
On the Resolutions Adopted at the Extraordinary General Meeting of Shareholders
-
Ottco and Royal Vopak sign strategic agreement to establish a joint venture in the special economic zone at Duqm
-
Alpha Modus Holdings, Inc. (NASDAQ: AMOD) To Launch AlphaCash, Appoints Puneet “Pete” Vij as VP of Technology to Lead Nationwide Rollout
-
Sound Group Collaborates With HKUST(GZ) To Cultivate AI Innovation Talent
-
A.P. Møller - Mærsk A/S – Transactions in connection with share buy-back program
-
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis
-
Kraig Biocraft Laboratories Promotes Dr. Xiaoli Zhang to Chief Scientist Following Series of Groundbreaking Scientific Breakthroughs
-
Arcadia Celebrates Customer Success, Innovation, and New AI-Driven Solutions at Aggregate 2025
-
Petal Health and Shoppers Drug Mart Collaborate to Expand Access to Care Across Canada
-
Heineken Holding N.V. reports transactions under its current share buyback programme
